Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Alternative Sweeteners Market Expected to Collect .6 Billion by 2031
    Alternative Sweeteners Market Expected to Collect $6.6 Billion by 2031 World News
  • The Inflation Reduction Act and What it Means for Methane Venting in the Natural Gas Industry
    The Inflation Reduction Act and What it Means for Methane Venting in the Natural Gas Industry World News
  • Maui and Sons Announces Holiday ’22 Collaboration With Corona®
    Maui and Sons Announces Holiday ’22 Collaboration With Corona® Business
  • Only Bahamian Ocean Club Estate & Private Beach on Paradise Island to Auction via Sotheby’s Concierge Auctions
    Only Bahamian Ocean Club Estate & Private Beach on Paradise Island to Auction via Sotheby’s Concierge Auctions World News
  • Law Office of Steers and Associates Announces Legal Support for Lyft Accident Injury Cases
    Law Office of Steers and Associates Announces Legal Support for Lyft Accident Injury Cases Business
  • Wearwell® Introduces Diamond-Plate Modular Rubber Flooring
    Wearwell® Introduces Diamond-Plate Modular Rubber Flooring Business
  • BayEcotarium Hosts Primary and Final Berkeley Innovation Forum Sessions
    BayEcotarium Hosts Primary and Final Berkeley Innovation Forum Sessions Business
  • Urban Re-Public by Aecom Wins Bronze in A’ Urban Design Awards
    Urban Re-Public by Aecom Wins Bronze in A’ Urban Design Awards Business
Nemysis Ltd and Faran S.A. Sign a Strategic Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac Disease

Nemysis Ltd and Faran S.A. Sign a Strategic Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac Disease

Posted on December 2, 2022 By NewsEditor
Nemysis Ltd and Faran S.A. Sign a Strategic Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac DiseaseNemysis Ltd and Faran S.A. Sign a Strategic Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac DiseaseDUBLIN - December 2, 2022 - (Newswire.com)

Nemysis Ltd today announces a Strategic Cooperation with Faran S.A., a leading Greek pharma company, for the development and later commercialization of its E40 endopeptidase as a novel enzymatic therapy for gluten degradation.

"Faran has a longstanding tradition in bringing to the Greek market innovative products and providing innovative solutions to tackle highly prevalent unmet medical conditions. The company has established over the years several strategic partnerships with established pharma companies from all over the world," said Danilo Casadei Massari, Nemysis's Chairman, and CEO. "We are pleased to cooperate in the late-stage development of E40, a novel enzymatic therapy for gluten degradation which will bring relief to the many patients suffering from symptoms of Celiac Disease. Faran will also be instrumental in defining the most effective route to the market for our product, which is expected to be on the market in late 2024."

Mr. Katsikas, President & CEO of Faran, commented on the agreement "expressing satisfaction for the new cooperation agreement which is further recognition of the key role of the company in the Greek market, spanning over 70 years of successful tradition. E40 will perfectly fit in our portfolio and complement our presence in the specific field."

About Faran:

FARAN S.A. is one of the most historic pharmaceutical companies in Greece, founded in 1950, and aims to offer renowned therapeutic proposals of high quality, therapeutic value, modern pharmaceutical technology, and documented safety.

With selected international collaborations and the trust of the medical community, it offers therapeutic solutions to a wide range of diseases in the field of Oncology, Hematology, Nephrology, Rheumatology, Orthopedics, Dermatology, Gastroenterology, Endocrinology, Pathology and Gynecology and, from Autumn 2022, also in Cardiology.

About Nemysis:

NEMYSIS LTD, a healthcare and pharmaceutical company, is focused on nutritional and pharmaceutical solutions that can protect against some of the negative consequences of nutrient deficiency, nutrient intolerances, and sensitivities, paying particular attention to the need to safeguard the human microbiome.

Nemysis's novel nanoparticulate iron is the first natural ferritin mimic, which can correct human iron deficiency and anemia, without negatively impacting the gut microbiome. Safety and efficacy have been demonstrated in controlled-repeat-dose clinical trials.

Nemysis's novel E40 endopeptidase is gastric, trypsin, and chymotrypsin resistant. It has been shown to destroy all the immuno-stimulatory epitopes of gluten, quenching the exacerbated inflammatory response of primed, gluten-sensitive, and hyper-responsive human T cells. It is, therefore, suitable for the enzymatic management of gluten intolerance and sensitivity.

www.nemysisltd.com

Danilo Casadei-Massari

Suite 4.01 Ormond Building

31-36 Ormond Quay Upper

Arran Quay D07 F6DC - Ireland +35315313450

[email protected]


Contact Information:
Danilo Casadei Massari
CEO
[email protected]
+35315313450


Press Release Service by Newswire.com

Original Source: Nemysis Ltd and Faran S.A. Sign a Strategic Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac Disease Nemysis Ltd and Faran S.A. Sign a Strategic Agreement to Cooperate for the Development of Endopeptidase E40 for Celiac Disease
Business

Post navigation

Previous Post: War Day 41 :: war chronicles with Advisor to Ukraine President, Intel Officer, Alexey Arestovych
Next Post: Ritani to Co-Host Holiday Gift Shop in East Village New York City

Related Posts

  • The Rosie Report Finds a Layered Workforce is a Key to Preventing Burnout and Adding Diversity in Thought and Expertise
    The Rosie Report Finds a Layered Workforce is a Key to Preventing Burnout and Adding Diversity in Thought and Expertise Business
  • Vapor Technology Association Questions FDA’s Youth Vaping Analysis
    Vapor Technology Association Questions FDA’s Youth Vaping Analysis Business
  • Over 100 Global Speakers to Participate in the 3rd Global Project Management Forum in Riyadh next week
    Over 100 Global Speakers to Participate in the 3rd Global Project Management Forum in Riyadh next week Business
  • Tidal Wave Auto Spa Raises 0,000 on 14th Annual Charity Day
    Tidal Wave Auto Spa Raises $350,000 on 14th Annual Charity Day Business
  • HiCamp Partners Joins EasyDMARC’s MSP Program to Enhance Email Security and Deliverability for Clients
    HiCamp Partners Joins EasyDMARC’s MSP Program to Enhance Email Security and Deliverability for Clients Business
  • Award-winning Film Producer Adriana Kostetska is making her directorial debut with ‘Sweet Struggle’
    Award-winning Film Producer Adriana Kostetska is making her directorial debut with ‘Sweet Struggle’ Business
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« May    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • International African Energy, Oil & Gas Summit (IAEOGS) 2025 Set for August in Namibia Amid Record Investment GrowthJune 20, 2025
  • Texas 5,000 Acre AI Data Center Site Fast Tracks 500 MW Behind-Meter PowerJune 19, 2025
  • Dylan Scott Embraces New Era with Reflective and Confident Studio Album ‘Easy Does It’June 19, 2025
  • Trusted Hauling Leader Blue Tree Resources Now Offers Demolition and Excavation Throughout Northern ColoradoJune 19, 2025
  • Lawn 316 Brings Quality Lawn Care and Lawn Mowing to Wichita, KSJune 18, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Cardone Ventures, Co-Founded by Grant Cardone and Brandon Dawson, Announces Partnership With Lilly’s Fresh Pasta
    Cardone Ventures, Co-Founded by Grant Cardone and Brandon Dawson, Announces Partnership With Lilly’s Fresh Pasta Business
  • FAA Hits 1,500-Controller Hiring Goal for 2023
    FAA Hits 1,500-Controller Hiring Goal for 2023 Aviation
  • HackerNoon Launches Onsite Polls and Tech Company News Reports
    HackerNoon Launches Onsite Polls and Tech Company News Reports Business
  • A Pathway to National Health Goals
    A Pathway to National Health Goals Business
  • IFIA Bharat Partners with the Office of the Principal Scientific Adviser (PSA) to the Government of India
    IFIA Bharat Partners with the Office of the Principal Scientific Adviser (PSA) to the Government of India World News
  • War in Ukraine, Analytics: “Arestovych Method” That He is Loved & Hated For.  by Inga Mezerya
    War in Ukraine, Analytics: “Arestovych Method” That He is Loved & Hated For. by Inga Mezerya World News
  • Resistance is Life by Sina Moloudnezhadnaghadeh Wins Iron A’ Design Award in Jewelry Design Category
    Resistance is Life by Sina Moloudnezhadnaghadeh Wins Iron A’ Design Award in Jewelry Design Category World News
  • getAbstract International Book Award 2022 Business Impact Shortlist Announced
    getAbstract International Book Award 2022 Business Impact Shortlist Announced Business
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .